@article{093f26a7b69f44709d7af1e208f69bf6,
title = "Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'",
keywords = "arthritis, psoriatic, cytokines, spondylitis, ankylosing, arthritis, ankylosing, spondylitis, psoriatic, Spondylarthritis/drug therapy, Humans, Arthritis, Psoriatic/drug therapy, Randomized Controlled Trials as Topic, Spondylitis, Spondylitis, Ankylosing, Axial Spondyloarthritis",
author = "Gladman, \{Dafna D\} and Mease, \{Philip J\} and Paul Bird and Soriano, \{Enrique R\} and Chakravarty, \{Soumya D\} and May Shawi and Frederic Lavie and Cinty Gong and Evan Leibowitz and Denis Poddubnyy and Lai-Shan Tam and Helliwell, \{Philip S\} and Arthur Kavanaugh and Deodhar, \{Atul A\} and Mikkel {\O}stergaard and Xenofon Baraliakos",
note = "COPECARE",
year = "2022",
month = aug,
doi = "10.1136/annrheumdis-2022-222161",
language = "English",
volume = "82",
pages = "e187",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "Elsevier BV",
number = "8",
}